IRIS UniCatt

Salvatore, Lisa
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.991
AS - Asia 1.471
EU - Europa 1.201
SA - Sud America 302
AF - Africa 42
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 5.009
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.928
SG - Singapore 690
DE - Germania 449
CN - Cina 286
BR - Brasile 241
IT - Italia 196
VN - Vietnam 165
SE - Svezia 127
FR - Francia 116
IN - India 84
GB - Regno Unito 69
FI - Finlandia 65
HK - Hong Kong 42
IE - Irlanda 41
JP - Giappone 39
ID - Indonesia 34
AT - Austria 29
BD - Bangladesh 27
AR - Argentina 26
CA - Canada 25
PL - Polonia 23
KR - Corea 22
MX - Messico 22
RU - Federazione Russa 16
ZA - Sudafrica 16
TR - Turchia 14
IQ - Iraq 12
NL - Olanda 12
EC - Ecuador 11
ES - Italia 11
VE - Venezuela 9
CZ - Repubblica Ceca 8
LT - Lituania 8
IR - Iran 7
JM - Giamaica 7
PK - Pakistan 7
RO - Romania 7
SA - Arabia Saudita 7
BE - Belgio 6
CI - Costa d'Avorio 6
UA - Ucraina 6
CO - Colombia 4
DZ - Algeria 4
KZ - Kazakistan 4
PY - Paraguay 4
UZ - Uzbekistan 4
CH - Svizzera 3
GE - Georgia 3
HN - Honduras 3
IL - Israele 3
KE - Kenya 3
PE - Perù 3
TH - Thailandia 3
TN - Tunisia 3
AE - Emirati Arabi Uniti 2
AZ - Azerbaigian 2
BY - Bielorussia 2
CL - Cile 2
EG - Egitto 2
MA - Marocco 2
MY - Malesia 2
NG - Nigeria 2
OM - Oman 2
PH - Filippine 2
PT - Portogallo 2
TW - Taiwan 2
UY - Uruguay 2
AL - Albania 1
AU - Australia 1
BW - Botswana 1
CR - Costa Rica 1
DM - Dominica 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
GR - Grecia 1
GT - Guatemala 1
HU - Ungheria 1
JO - Giordania 1
KG - Kirghizistan 1
LK - Sri Lanka 1
LV - Lettonia 1
LY - Libia 1
NP - Nepal 1
PA - Panama 1
PS - Palestinian Territory 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
TM - Turkmenistan 1
TT - Trinidad e Tobago 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 5.009
Salva come PNG Salva come JPEG
Città #
Ashburn 639
Singapore 417
San Jose 178
Chandler 152
Los Angeles 85
Rome 74
Beijing 63
Ho Chi Minh City 62
New York 60
Hyderabad 57
Hefei 54
Helsinki 44
Lauterbourg 43
Dublin 41
Hong Kong 41
Hanoi 40
The Dalles 40
Tokyo 39
Munich 37
Frankfurt am Main 30
Council Bluffs 29
Chicago 27
Jakarta 26
São Paulo 25
Santa Clara 24
Boston 23
Milan 23
Vienna 23
Seoul 21
London 19
Orem 18
Marseille 17
Dallas 16
Princeton 16
Houston 14
Kent 14
Warsaw 14
Lappeenranta 13
Cattolica 12
Johannesburg 12
Denver 11
Mexico City 11
Nuremberg 11
St Louis 11
Toronto 11
Buffalo 10
Bexley 9
Poplar 9
Wilmington 9
Boardman 8
Columbus 8
Falkenstein 8
Haiphong 8
Hải Dương 8
Montreal 8
Moscow 8
Paris 8
Stockholm 8
Turku 8
Amsterdam 7
Atlanta 7
Bremen 7
Curitiba 7
Hamburg 7
Portsmouth 7
Rio de Janeiro 7
San Mateo 7
Abidjan 6
Buenos Aires 6
Kingston 6
Manchester 6
Roubaix 6
Salt Lake City 6
Ankara 5
Baghdad 5
Bari 5
Brasília 5
Brooklyn 5
Brussels 5
Da Nang 5
Düsseldorf 5
Kampong Loyang 5
Phoenix 5
Querétaro 5
Redmond 5
Seattle 5
Shanghai 5
Washington 5
Biên Hòa 4
Brdo 4
Chennai 4
Concord 4
Dhaka 4
Goiânia 4
Guangzhou 4
Guayaquil 4
Kish 4
Mumbai 4
Riyadh 4
Secaucus 4
Totale 2.969
Salva come PNG Salva come JPEG
Nome #
Discordance of KRAS Mutational Status between Primary Tumors and Liver Metastases in Colorectal Cancer: Impact on Long-Term Survival Following Radical Resection 614
THUNDER 2: THeragnostic Utilities for Neoplastic DisEases of the Rectum by MRI guided radiotherapy 505
The impact of the multidisciplinary tumor board (MDTB) on the management of pancreatic diseases in a tertiary referral center 191
Challenges in crohn’s disease management after gastrointestinal cancer diagnosis 157
Management of single pulmonary metastases from colorectal cancer: State of the art 152
Clinical, pathological and prognostic features of rare braf mutations in metastatic colorectal cancer (Mcrc): A bi-institutional retrospective analysis (rebus study) 150
Nutritional Interventions during Chemotherapy for Pancreatic Cancer: A Systematic Review of Prospective Studies 145
Comparison of first-line chemotherapy regimens in unresectable locally advanced or metastatic pancreatic cancer: a systematic review and Bayesian network meta-analysis 133
The Impact of a Multidisciplinary Tumor Board (MDTB) in the Management of Colorectal Cancer (CRC) 129
Conversion Therapy With Encorafenib and Cetuximab for Chemo-Refractory BRAF V600E-Mutated Liver-Limited Colorectal Cancer Metastasis: The First Case Report 129
Temozolomide Followed by Combination With Low-Dose Ipilimumab and Nivolumab in Patients With Microsatellite-Stable, O6-Methylguanine-DNA Methyltransferase-Silenced Metastatic Colorectal Cancer: The MAYA Trial 128
The role of the multidisciplinary tumor board (MDTB) in the assessment of pancreatic cancer diagnosis and resectability: A tertiary referral center experience 127
Nutritional Interventions during Chemotherapy for Pancreatic Cancer: A Systematic Review of Prospective Studies 127
Ascites and resistance to immune checkpoint inhibition in dMMR/MSI-H metastatic colorectal and gastric cancers 123
MetaLiverCat: the NAFLD/NASH multidisciplinary board at Fondazione Policlinico Gemelli IRCCS 120
Treatment of patients with BRAFV600E-mutated metastatic colorectal cancer after progression to encorafenib and cetuximab: data from a real-world nationwide dataset 119
Bevacizumab as maintenance therapy in patients with metastatic colorectal cancer: A meta-analysis of individual patients’ data from 3 phase III studies 118
Challenges in Crohn's Disease Management after Gastrointestinal Cancer Diagnosis 117
Role of chemoradiation (CRT) in the adjuvant treatment of radically resected pancreatic cancer (PC) patients (pts): a mono-institutional retrospective analysis 117
Efficacy of third-line anti-EGFR-based treatment versus regorafenib or trifluridine/tipiracil according to primary tumor site in RAS/BRAF wild-type metastatic colorectal cancer patients 112
Codon-specific KRAS mutations predict survival benefit of trifluridine/tipiracil in metastatic colorectal cancer 109
The impact of the histological classification of ampullary carcinomas on long-term outcomes after pancreaticoduodenectomy: a single tertiary referral center evaluation 109
Role of Chemoradiation in the Adjuvant Treatment of Radically Resected Pancreatic Cancer Patients: A Mono-Institutional Retrospective Analysis 107
Upfront Fluorouracil, Leucovorin, Oxaliplatin, and Irinotecan Plus Bevacizumab with or Without Atezolizumab for Patients with Metastatic Colorectal Cancer: Updated and Overall Survival Results of the ATEZOTRIBE Study 101
Maintenance strategies after anti-EGFR-based induction in metastatic colorectal cancer: A systematic review and bayesian network meta-analysis 100
Sotorasib plus Panitumumab in Refractory Colorectal Cancer with Mutated KRAS G12C 94
PTEN in colorectal cancer: Shedding light on its role as predictor and target 92
Prognostic impact of early nutritional support in patients affected by locally advanced and metastatic pancreatic ductal adenocarcinoma undergoing chemotherapy 87
Predicting early recurrence after resection of initially unresectable colorectal liver metastases: the role of baseline and pre-surgery clinical, radiological and molecular factors in a real-life multicentre experience 83
Overall Survival Analysis of the Phase III CodeBreaK 300 Study of Sotorasib Plus Panitumumab Versus Investigator's Choice in Chemorefractory KRAS G12C Colorectal Cancer 80
An Immune-Related Gene Expression Signature Predicts Benefit from Adding Atezolizumab to FOLFOXIRI plus Bevacizumab in Metastatic Colorectal Cancer 79
Upfront FOLFOXIRI plus bevacizumab with or without atezolizumab in the treatment of patients with metastatic colorectal cancer (AtezoTRIBE): a multicentre, open-label, randomised, controlled, phase 2 trial 75
Activity and safety of cetuximab plus modified folfoxiri followed by maintenance with cetuximab or bevacizumab for RAS and BRAF wild-type metastatic colorectal cancer a randomized phase 2 clinical trial 74
Challenges in Crohn's Disease Management after Gastrointestinal Cancer Diagnosis 73
Clinico-pathological nomogram for predicting BRAF mutational status of metastatic colorectal cancer 71
Dissecting tumor lymphocyte infiltration to predict benefit from immune-checkpoint inhibitors in metastatic colorectal cancer: Lessons from the AtezoT RIBE study 68
Management of patients with early-stage colon cancer: Guidelines of the Italian Medical Oncology Association 63
Colorectal cancer patients-derived immunity-organoid platform unveils cancer-specific tissue markers associated with immunotherapy resistance 55
A validated prognostic classifier for V600EBRAF-mutated metastatic colorectal cancer: the ‘BRAF BeCool’ study 53
Totale 5.086
Salva come PNG Salva come JPEG
Categoria #
all - tutte 17.321
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 17.321
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20215 0 0 0 0 0 0 0 0 0 0 5 0
2021/2022135 8 2 0 13 5 3 2 16 4 11 37 34
2022/2023435 42 46 35 68 36 53 26 27 42 14 16 30
2023/2024755 10 50 27 22 17 38 244 255 2 14 37 39
2024/2025921 12 11 57 32 53 40 73 31 102 120 235 155
2025/20262.810 291 117 207 459 455 452 330 149 191 153 6 0
Totale 5.086